Epigenetics and diabetes treatment: an unrealized promise?

Trends Endocrinol Metab. 2012 Jun;23(6):286-91. doi: 10.1016/j.tem.2012.02.002. Epub 2012 Mar 14.

Abstract

Epigenetic mechanisms may contribute to the pathogenesis of complex diseases. Early or late environmental influences such as intrauterine malnutrition or sedentary lifestyle have been shown to lead to an increased risk of diabetes. Recently, epigenetic mechanisms were shown to be involved in endocrine cell differentiation and islet function. Genomic profiling of pancreatic islets in non-diabetic and diabetic states is needed in order to dissect the contribution of epigenetic mechanisms to the declining proliferation potential of β cells that we see with aging or the β-cell failure observed in diabetes. In-depth understanding of epigenetic landscapes can help to improve protocols for in vitro differentiation towards the β-cell fate, enhance β-cell proliferation, and lead to the discovery of novel therapeutic targets.

Publication types

  • Review

MeSH terms

  • Aging / physiology
  • Animals
  • Cell Differentiation / physiology
  • Cell Proliferation
  • Diabetes Mellitus / genetics*
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / therapy*
  • Epigenomics / trends*
  • Humans
  • Insulin-Secreting Cells / cytology
  • Insulin-Secreting Cells / physiology
  • Models, Animal